Induction and function of type I and III interferon in response to viral infection

Current Opinion in Virology - Tập 1 Số 6 - Trang 476-486 - 2011
David E. Levy1,2, Isabelle Marié2, Joan E. Durbin2
1Department of Microbiology, NYU School of Medicine, 550 1st Ave, New York, NY 10016, USA
2Department of Pathology, NYU School of Medicine, 550 1st Ave, New York, NY 10016, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Donnelly, 2010, Interferon-lambda: a new addition to an old family, J Interferon Cytokine Res, 30, 555, 10.1089/jir.2010.0078

Iversen, 2010, Mechanisms of type III interferon expression, J Interferon Cytokine Res, 30, 573, 10.1089/jir.2010.0063

Stetson, 2006, Type I interferons in host defense, Immunity, 25, 373, 10.1016/j.immuni.2006.08.007

Lin, 2011, Posttranscriptional control of type I interferon genes by KSRP in the innate immune response against viral infection, Mol Cell Biol, 31, 3196, 10.1128/MCB.05073-11

Marie, 1998, Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7, EMBO J, 17, 6660, 10.1093/emboj/17.22.6660

Levy, 2005, How viruses elicit interferon production: triggering the innate immune response to viral infection

Ford, 2010, The transcriptional code of human IFN-beta gene expression, Biochim Biophys Acta, 1799, 328, 10.1016/j.bbagrm.2010.01.010

Taniguchi, 2001, IRF family of transcription factors as regulators of host defense, Annu Rev Immunol, 19, 623, 10.1146/annurev.immunol.19.1.623

Paun, 2007, The IRF family, revisited, Biochimie, 89, 744, 10.1016/j.biochi.2007.01.014

Ye, 2011, Negative regulation of interferon-beta gene expression during acute and persistent virus infections, PLoS One, 6, e20681, 10.1371/journal.pone.0020681

Goodbourn, 1990, The regulation of beta-interferon gene expression, Semin Cancer Biol, 1, 89

Maniatis, 1998, Structure and function of the interferon-beta enhanceosome, Cold Spring Harb Symp Quant Biol, 63, 609, 10.1101/sqb.1998.63.609

Lin, 1994, Mutational analysis of interferon (IFN) regulatory factors 1 and 2. Effects on the induction of IFN-beta gene expression, J Biol Chem, 269, 17542, 10.1016/S0021-9258(17)32475-4

Chen, 2010, Heterocellular induction of interferon by negative-sense RNA viruses, Virology, 407, 247, 10.1016/j.virol.2010.08.008

Apostolou, 2008, Virus infection induces NF-kappaB-dependent interchromosomal associations mediating monoallelic IFN-beta gene expression, Cell, 134, 85, 10.1016/j.cell.2008.05.052

Sato, 2000, Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction, Immunity, 13, 539, 10.1016/S1074-7613(00)00053-4

Hata, 2001, Constitutive IFN-alpha/beta signal for efficient IFN-alpha/beta gene induction by virus, Biochem Biophys Res Commun, 285, 518, 10.1006/bbrc.2001.5159

Agalioti, 2000, Ordered recruitment of chromatin modifying and general transcription factors to the IFN-beta promoter, Cell, 103, 667, 10.1016/S0092-8674(00)00169-0

Horn, 2001, The bromodomain: a regulator of ATP-dependent chromatin remodeling?, Front Biosci, 6, D1019, 10.2741/Horn

Lomvardas, 2002, Modifying gene expression programs by altering core promoter chromatin architecture, Cell, 110, 261, 10.1016/S0092-8674(02)00822-X

Tamura, 2008, The IRF family transcription factors in immunity and oncogenesis, Annu Rev Immunol, 26, 535, 10.1146/annurev.immunol.26.021607.090400

Tailor, 2007, The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8, Immunity, 27, 228, 10.1016/j.immuni.2007.06.009

Levy, 2003, Ringing the interferon alarm: differential regulation of gene expression at the interface between innate and adaptive immunity, Curr Opin Immunol, 15, 52, 10.1016/S0952-7915(02)00011-0

Genin, 2009, The role of differential expression of human interferon—a genes in antiviral immunity, Cytokine Growth Factor Rev, 20, 283, 10.1016/j.cytogfr.2009.07.005

Gough, 2010, Functional crosstalk between type I and II interferon through the regulated expression of STAT1, PLoS Biol, 8, e1000361, 10.1371/journal.pbio.1000361

Gough DJ, Messina NL, Clark CPJ, Levy DE, Johnstone RW: Constitutive type I interferon secretion positively and negatively modulates homeostatic balance. Immunity 2011, in press.

Onoguchi, 2007, Viral infections activate types I and III interferon genes through a common mechanism, J Biol Chem, 282, 7576, 10.1074/jbc.M608618200

Osterlund, 2007, IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes, J Immunol, 179, 3434, 10.4049/jimmunol.179.6.3434

Iversen, 2010, Expression of type III interferon (IFN) in the vaginal mucosa is mediated primarily by dendritic cells and displays stronger dependence on NF-kappaB than type I IFNs, J Virol, 84, 4579, 10.1128/JVI.02591-09

Thomson, 2009, The role of transposable elements in the regulation of IFN-lambda1 gene expression, Proc Natl Acad Sci U S A, 106, 11564, 10.1073/pnas.0904477106

Thomas, 2009, Genetic variation in IL28B and spontaneous clearance of hepatitis C virus, Nature, 461, 798, 10.1038/nature08463

Tanaka, 2009, Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C, Nat Genet, 41, 1105, 10.1038/ng.449

Suppiah, 2009, IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy, Nat Genet, 41, 1100, 10.1038/ng.447

O’Neill, 2010, Sensing and signaling in antiviral innate immunity, Curr Biol, 20, R328, 10.1016/j.cub.2010.01.044

Satoh, 2010, LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses, Proc Natl Acad Sci U S A, 107, 1512, 10.1073/pnas.0912986107

Pollpeter, 2011, Impaired cellular responses to cytosolic DNA or infection with Listeria monocytogenes and vaccinia virus in the absence of the murine LGP2 protein, PLoS One, 6, e18842, 10.1371/journal.pone.0018842

Zeng, 2010, Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity, Cell, 141, 315, 10.1016/j.cell.2010.03.029

Hou, 2011, MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response, Cell, 146, 448, 10.1016/j.cell.2011.06.041

Oganesyan, 2006, Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response, Nature, 439, 208, 10.1038/nature04374

Wertz, 2010, Signaling to NF-kappaB: regulation by ubiquitination, Cold Spring Harb Perspect Biol, 2, a003350, 10.1101/cshperspect.a003350

Ishikawa, 2008, STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling, Nature, 455, 674, 10.1038/nature07317

Zhong, 2008, The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation, Immunity, 29, 538, 10.1016/j.immuni.2008.09.003

Chien, 2006, RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival, Cell, 127, 157, 10.1016/j.cell.2006.08.034

Ishikawa, 2009, STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity, Nature, 461, 788, 10.1038/nature08476

Tsuchida, 2010, The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA, Immunity, 33, 765, 10.1016/j.immuni.2010.10.013

Miyashita, 2011, DDX60, a DEXD/H box helicase, is a novel antiviral factor promoting RIG-I-like receptor-mediated signaling, Mol Cell Biol, 31, 3802, 10.1128/MCB.01368-10

Soulat, 2008, The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response, EMBO J, 27, 2135, 10.1038/emboj.2008.126

Schroder, 2008, Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation, EMBO J, 27, 2147, 10.1038/emboj.2008.143

Mulhern, 2010, Unexpected roles for DEAD-box protein 3 in viral RNA sensing pathways, Eur J Immunol, 40, 933, 10.1002/eji.201040447

Levy, 2002, Whence interferon? Variety in the production of interferon in response to viral infection, J Exp Med, 195, F15, 10.1084/jem.20020075

Blasius, 2010, Intracellular toll-like receptors, Immunity, 32, 305, 10.1016/j.immuni.2010.03.012

Tun-Kyi, 2011, Essential role for the prolyl isomerase Pin1 in Toll-like receptor signaling and type I interferon-mediated immunity, Nat Immunol, 12, 733, 10.1038/ni.2069

Wang, 2008, Differential regulation of IKK alpha-mediated activation of IRF3/7 by NIK, Mol Immunol, 45, 1926, 10.1016/j.molimm.2007.10.034

Hoshino, 2006, IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9, Nature, 440, 949, 10.1038/nature04641

Shinohara, 2006, Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells, Nat Immunol, 7, 498, 10.1038/ni1327

Seya, 2009, Functional evolution of the TICAM-1 pathway for extrinsic RNA sensing, Immunol Rev, 227, 44, 10.1111/j.1600-065X.2008.00723.x

Sasai, 2006, NAK-associated protein 1 participates in both the TLR3 and the cytoplasmic pathways in type I IFN induction, J Immunol, 177, 8676, 10.4049/jimmunol.177.12.8676

Sasai, 2010, Direct binding of TRAF2 and TRAF6 to TICAM-1/TRIF adaptor participates in activation of the Toll-like receptor 3/4 pathway, Mol Immunol, 47, 1283, 10.1016/j.molimm.2009.12.002

Sharma, 2011, Innate immune sensing of DNA, PLoS Pathog, 7, e1001310, 10.1371/journal.ppat.1001310

Barber, 2011, Cytoplasmic DNA innate immune pathways, Immunol Rev, 243, 99, 10.1111/j.1600-065X.2011.01051.x

de Weerd, 2007, Type I interferon receptors: biochemistry and biological functions, J Biol Chem, 282, 20053, 10.1074/jbc.R700006200

Levy, 1988, Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional control, Genes Dev, 2, 383, 10.1101/gad.2.4.383

Kotenko, 2003, IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex, Nat Immunol, 4, 69, 10.1038/ni875

Sheppard, 2003, IL-28, IL-29 and their class II cytokine receptor IL-28R, Nat Immunol, 4, 63, 10.1038/ni873

Doyle, 2006, Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes, Hepatology, 44, 896, 10.1002/hep.21312

Schindler, 2007, JAK-STAT signaling: from interferons to cytokines, J Biol Chem, 282, 20059, 10.1074/jbc.R700016200

Bustamante, 2008, Novel primary immunodeficiencies revealed by the investigation of pediatric infectious disease, Curr Opin Immunol, 20, 39, 10.1016/j.coi.2007.10.005

Dupuis, 2003, Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency, Nat Genet, 33, 388, 10.1038/ng1097

Gil, 2001, Biologic consequences of Stat1-independent IFN signaling, Proc Natl Acad Sci U S A, 98, 6680, 10.1073/pnas.111163898

Price, 2000, The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice, J Virol, 74, 3996, 10.1128/JVI.74.9.3996-4003.2000

Johnson, 2005, Role for innate IFNs in determining respiratory syncytial virus immunopathology, J Immunol, 174, 7234, 10.4049/jimmunol.174.11.7234

Sommereyns, 2008, IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo, PLoS Pathog, 4, e1000017, 10.1371/journal.ppat.1000017

Mordstein, 2010, Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections, J Virol, 84, 5670, 10.1128/JVI.00272-10

Pott, 2011, IFN-lambda determines the intestinal epithelial antiviral host defense, Proc Natl Acad Sci U S A, 108, 7944, 10.1073/pnas.1100552108

Jewell, 2010, Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo, J Virol, 84, 11515, 10.1128/JVI.01703-09

Okabayashi, 2011, Type-III interferon, not type-I, is the predominant interferon induced by respiratory viruses in nasal epithelial cells, Virus Res, 160, 360, 10.1016/j.virusres.2011.07.011

Muir, 2010, Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection, Hepatology, 52, 822, 10.1002/hep.23743

Francois-Newton, 2011, USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon alpha response, PLoS One, 6, e22200, 10.1371/journal.pone.0022200

Ito, 2001, Differential regulation of human blood dendritic cell subsets by IFNs, J Immunol, 166, 2961, 10.4049/jimmunol.166.5.2961

Montoya, 2002, Type I interferons produced by dendritic cells promote their phenotypic and functional activation, Blood, 99, 3263, 10.1182/blood.V99.9.3263

Le Bon, 2001, Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo, Immunity, 14, 461, 10.1016/S1074-7613(01)00126-1

Padovan, 2002, IFN-alpha2a induces IP-10/CXCL10 and MIG/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells, J Leukoc Biol, 71, 669, 10.1189/jlb.71.4.669

Mattei, 2001, IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation, J Immunol, 167, 1179, 10.4049/jimmunol.167.3.1179

Litinskiy, 2002, DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL, Nat Immunol, 3, 822, 10.1038/ni829

Le Bon, 2003, Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon, Nat Immunol, 4, 1009, 10.1038/ni978

Nguyen, 2002, Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection, Science, 297, 2063, 10.1126/science.1074900

Gil, 2006, Modulation of STAT1 protein levels: a mechanism shaping CD8 T-cell responses in vivo, Blood, 107, 987, 10.1182/blood-2005-07-2834

Miyagi, 2007, High basal STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer cells, J Exp Med, 204, 2383, 10.1084/jem.20070401

van Boxel-Dezaire, 2010, Major differences in the responses of primary human leukocyte subsets to IFN-beta, J Immunol, 185, 5888, 10.4049/jimmunol.0902314

Mack, 2011, Type I interferon induction of natural killer cell gamma interferon production for defense during lymphocytic choriomeningitis virus infection, MBio, 2, 10.1128/mBio.00169-11

Adamson, 2009, The Current STATus of lymphocyte signaling: new roles for old players, Curr Opin Immunol, 21, 161, 10.1016/j.coi.2009.03.013

Wang, 2011, STAT3 negatively regulates type I IFN-mediated antiviral response, J Immunol, 187, 2578, 10.4049/jimmunol.1004128

Morinobu, 2002, STAT4 serine phosphorylation is critical for IL-12-induced IFN-gamma production but not for cell proliferation, Proc Natl Acad Sci U S A, 99, 12281, 10.1073/pnas.182618999

Wei, 2010, Discrete role of STAT4 and STAT6 transcription factors in tuning epigenetic modifications and transcription during T helper cell differentiation, Immunity, 32, 840, 10.1016/j.immuni.2010.06.003

van Boxel-Dezaire, 2006, Complex modulation of cell type-specific signaling in response to type I interferons, Immunity, 25, 361, 10.1016/j.immuni.2006.08.014

Lasfar, 2006, Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma, Cancer Res, 66, 4468, 10.1158/0008-5472.CAN-05-3653

Diegelmann, 2010, Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus, PLoS One, 5, e15200, 10.1371/journal.pone.0015200

Witte, 2009, Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines, Genes Immun, 10, 702, 10.1038/gene.2009.72

Dai, 2009, IFN-lambda1 (IL-29) inhibits GATA3 expression and suppresses Th2 responses in human naive and memory T cells, Blood, 113, 5829, 10.1182/blood-2008-09-179507

Megjugorac, 2009, Modulation of human plasmacytoid DC function by IFN-lambda1 (IL-29), J Leukoc Biol, 86, 1359, 10.1189/jlb.0509347

Mennechet, 2006, Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells, Blood, 107, 4417, 10.1182/blood-2005-10-4129

Robek, 2005, Lambda interferon inhibits hepatitis B and C virus replication, J Virol, 79, 3851, 10.1128/JVI.79.6.3851-3854.2005